As Taiwan accelerates its transformation into a leading biomanufacturing hub under its ‘5+2’ Innovative Industries Plan, Biologics World Taiwan 2027 returns at a pivotal moment for the region’s biotech ecosystem.
Building on over a decade of excellence, the conference continues to serve as the country’s premier platform uniting 300+ local and global leaders across biologics manufacturing, R&D, and clinical trials. Taiwan’s government has sharpened its focus on biomedicine, aiming to replicate its semiconductor success story in the biotech sector. This vision is backed by action: in 2025 alone, the government has increased its science and technology budget to NT$146.6 billion (approx. USD 4.6 billion)—a nearly 15% rise—to fund AI-driven medical R&D and national talent development across ministries.
The launch of the Taiwan Bio-Manufacturing Corporation (TBMC)—modeled after TSMC and with 40% government ownership—marks a bold step in anchoring Taiwan as a regional powerhouse for biologics manufacturing. Meanwhile, the experience during the COVID-19 pandemic has only deepened Taiwan’s resolve to secure domestic CDMO capacity for advanced biologics, highlighting its importance to national health security.
At this year’s summit, expect deep-dive discussions into:
-
AI-powered innovations in biologics R&D
-
Scaling biomanufacturing capacity with CDMO excellence
-
Gene and cell therapy advancements, including CAR-T and stem cell applications
-
Optimisation in upstream and downstream processes
-
Case studies on mRNA, HIV, and dengue vaccine development
-
Taiwan's strategy for global biotech market expansion
With 172 biotech companies officially recognised by the MOEA, and several already listed on international stock exchanges, Taiwan’s biologics industry is on the cusp of something extraordinary. Biologics World Taiwan 2026 offers the unmatched opportunity to engage with frontrunners such as PharmaEssentia, Eirgenix, Medigen Biotechnology Corp, Lumosa Therapeutics, Mycenax, and many more.
If you're looking to understand where Taiwan’s biologics industry is heading—and how your organisation can be part of its growth—this is the summit you cannot afford to miss.
.png)
Taiwan
.png)
%20(1)%20(1).png)
%20Logo.png)
